The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Morgan Bradley Paul since 2017.
The trader's CIK number is 1659025.
At the time of the last reporting, Morgan Bradley Paul was the SVP Drug Discovery & Early Dev of Cytokinetics Inc. (stock ticker symbol CYTK).
Also see all insider trading activities at Cytokinetics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | CYTK | 0 | $0 | 118,330 | $1,774,950 | 118,330 | $1,023,436 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-08-31 | CYTK | Sale | 118,330 | 15.00 | 1,774,950 |
| 2017-08-31 | CYTK | Option Ex | 118,330 | 8.65 | 1,023,436 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morgan Bradley Paul (SVP Drug Discovery & Early Dev of Cytokinetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.